Industry: Chemical & Material
Published Date: 2025-02-15
Pages: 101 Pages
Report ld: 3957481
Request Sample
Customized Report
The global market for Fentanyl API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Fentanyl API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fentanyl API by region & country, by Type, and by Application.
The Fentanyl API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fentanyl API.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fentanyl API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Fentanyl API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Fentanyl API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Fentanyl API Product Introduction
1.2 Global Fentanyl API Market Size Forecast
1.2.1 Global Fentanyl API Sales Value (2020-2031)
1.2.2 Global Fentanyl API Sales Volume (2020-2031)
1.2.3 Global Fentanyl API Sales Price (2020-2031)
1.3 Fentanyl API Market Trends & Drivers
1.3.1 Fentanyl API Industry Trends
1.3.2 Fentanyl API Market Drivers & Opportunity
1.3.3 Fentanyl API Market Challenges
1.3.4 Fentanyl API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Fentanyl API Players Revenue Ranking (2024)
2.2 Global Fentanyl API Revenue by Company (2020-2025)
2.3 Global Fentanyl API Players Sales Volume Ranking (2024)
2.4 Global Fentanyl API Sales Volume by Company Players (2020-2025)
2.5 Global Fentanyl API Average Price by Company (2020-2025)
2.6 Key Manufacturers Fentanyl API Manufacturing Base and Headquarters
2.7 Key Manufacturers Fentanyl API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Fentanyl API
2.9 Fentanyl API Market Competitive Analysis
2.9.1 Fentanyl API Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Fentanyl API Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fentanyl API as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity 98%
3.1.2 Purity 99%
3.2 Global Fentanyl API Sales Value by Type
3.2.1 Global Fentanyl API Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Fentanyl API Sales Value, by Type (2020-2031)
3.2.3 Global Fentanyl API Sales Value, by Type (%) (2020-2031)
3.3 Global Fentanyl API Sales Volume by Type
3.3.1 Global Fentanyl API Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Fentanyl API Sales Volume, by Type (2020-2031)
3.3.3 Global Fentanyl API Sales Volume, by Type (%) (2020-2031)
3.4 Global Fentanyl API Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablets
4.1.2 Lollipop
4.1.3 Spray
4.1.4 Injectant
4.1.5 Others
4.2 Global Fentanyl API Sales Value by Application
4.2.1 Global Fentanyl API Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Fentanyl API Sales Value, by Application (2020-2031)
4.2.3 Global Fentanyl API Sales Value, by Application (%) (2020-2031)
4.3 Global Fentanyl API Sales Volume by Application
4.3.1 Global Fentanyl API Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Fentanyl API Sales Volume, by Application (2020-2031)
4.3.3 Global Fentanyl API Sales Volume, by Application (%) (2020-2031)
4.4 Global Fentanyl API Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Fentanyl API Sales Value by Region
5.1.1 Global Fentanyl API Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Fentanyl API Sales Value by Region (2020-2025)
5.1.3 Global Fentanyl API Sales Value by Region (2026-2031)
5.1.4 Global Fentanyl API Sales Value by Region (%), (2020-2031)
5.2 Global Fentanyl API Sales Volume by Region
5.2.1 Global Fentanyl API Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Fentanyl API Sales Volume by Region (2020-2025)
5.2.3 Global Fentanyl API Sales Volume by Region (2026-2031)
5.2.4 Global Fentanyl API Sales Volume by Region (%), (2020-2031)
5.3 Global Fentanyl API Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Fentanyl API Sales Value, 2020-2031
5.4.2 North America Fentanyl API Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Fentanyl API Sales Value, 2020-2031
5.5.2 Europe Fentanyl API Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Fentanyl API Sales Value, 2020-2031
5.6.2 Asia Pacific Fentanyl API Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Fentanyl API Sales Value, 2020-2031
5.7.2 South America Fentanyl API Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Fentanyl API Sales Value, 2020-2031
5.8.2 Middle East & Africa Fentanyl API Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Fentanyl API Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Fentanyl API Sales Value
6.2.1 Key Countries/Regions Fentanyl API Sales Value, 2020-2031
6.2.2 Key Countries/Regions Fentanyl API Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Fentanyl API Sales Value, 2020-2031
6.3.2 United States Fentanyl API Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Fentanyl API Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Fentanyl API Sales Value, 2020-2031
6.4.2 Europe Fentanyl API Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Fentanyl API Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Fentanyl API Sales Value, 2020-2031
6.5.2 China Fentanyl API Sales Value by Type (%), 2024 VS 2031
6.5.3 China Fentanyl API Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Fentanyl API Sales Value, 2020-2031
6.6.2 Japan Fentanyl API Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Fentanyl API Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Fentanyl API Sales Value, 2020-2031
6.7.2 South Korea Fentanyl API Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Fentanyl API Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Fentanyl API Sales Value, 2020-2031
6.8.2 Southeast Asia Fentanyl API Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Fentanyl API Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Fentanyl API Sales Value, 2020-2031
6.9.2 India Fentanyl API Sales Value by Type (%), 2024 VS 2031
6.9.3 India Fentanyl API Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Mylan
7.1.1 Mylan Company Information
7.1.2 Mylan Introduction and Business Overview
7.1.3 Mylan Fentanyl API Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Mylan Fentanyl API Product Offerings
7.1.5 Mylan Recent Development
7.2 AMRI
7.2.1 AMRI Company Information
7.2.2 AMRI Introduction and Business Overview
7.2.3 AMRI Fentanyl API Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 AMRI Fentanyl API Product Offerings
7.2.5 AMRI Recent Development
7.3 Cambrex
7.3.1 Cambrex Company Information
7.3.2 Cambrex Introduction and Business Overview
7.3.3 Cambrex Fentanyl API Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Cambrex Fentanyl API Product Offerings
7.3.5 Cambrex Recent Development
7.4 Rusan Pharma
7.4.1 Rusan Pharma Company Information
7.4.2 Rusan Pharma Introduction and Business Overview
7.4.3 Rusan Pharma Fentanyl API Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Rusan Pharma Fentanyl API Product Offerings
7.4.5 Rusan Pharma Recent Development
7.5 Johnson Matthey
7.5.1 Johnson Matthey Company Information
7.5.2 Johnson Matthey Introduction and Business Overview
7.5.3 Johnson Matthey Fentanyl API Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Johnson Matthey Fentanyl API Product Offerings
7.5.5 Johnson Matthey Recent Development
7.6 Northern Synthesis
7.6.1 Northern Synthesis Company Information
7.6.2 Northern Synthesis Introduction and Business Overview
7.6.3 Northern Synthesis Fentanyl API Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Northern Synthesis Fentanyl API Product Offerings
7.6.5 Northern Synthesis Recent Development
7.7 Mallinckrodt
7.7.1 Mallinckrodt Company Information
7.7.2 Mallinckrodt Introduction and Business Overview
7.7.3 Mallinckrodt Fentanyl API Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Mallinckrodt Fentanyl API Product Offerings
7.7.5 Mallinckrodt Recent Development
7.8 Arevipharma GmbH
7.8.1 Arevipharma GmbH Company Information
7.8.2 Arevipharma GmbH Introduction and Business Overview
7.8.3 Arevipharma GmbH Fentanyl API Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Arevipharma GmbH Fentanyl API Product Offerings
7.8.5 Arevipharma GmbH Recent Development
8 Industry Chain Analysis
8.1 Fentanyl API Industrial Chain
8.2 Fentanyl API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Fentanyl API Sales Model
8.5.2 Sales Channel
8.5.3 Fentanyl API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Fentanyl API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 135
USD 3950.00
(Single User License)
The global Fentanyl API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 131
USD 2900.00
(Single User License)
The global Fentanyl API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 141
USD 4900.00
(Single User License)
The global market for Fentanyl API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 94
USD 2900.00
(Single User License)
The global Fentanyl API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 78
USD 4250.00
(Single User License)
Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.
Published Date: 2024-04-07
Pages: 88
USD 4900.00
(Single User License)
Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.
Published Date: 2024-02-19
Pages: 101
USD 3950.00
(Single User License)
Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.
Published Date: 2024-01-11
Pages: 93
USD 2900.00
(Single User License)
The global market for Fentanyl API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 135
The global Fentanyl API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 131
The global Fentanyl API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 141
The global market for Fentanyl API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 94
The global Fentanyl API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 78
Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.
Published: 2024-04-07
Pages: 88
Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.
Published: 2024-02-19
Pages: 101
Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.
Published: 2024-01-11
Pages: 93
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now